PuSH - Publikationsserver des Helmholtz Zentrums München: A beta 43-producing PS1 FAD mutants cause altered substrate interactions and respond to gamma-secretase modulation.

Informationen

Hinweise zu Qualitätskriterien von Zeitschriften

Open-Access-Richtlinie der Helmholtz-Gemeinschaft 2016

CC Licencences

Metriken für Publikationen

Navigation

Startseite

English

EVA: Veröffentlichen

Neuer EVA Antrag

Recherche

Erweiterte Suche

Durchblättern nach ...

... HMGU-Autoren/Konsortien

... Organisationsstruktur

... Zeitschriften

... Publikationstypen

... Forschungsdaten

... Arbeitsgruppen

... Erscheinungsjahr

Publikationen im Überblick

Statistik

HGF Fortschrittsbericht

OA Publikationen

Eintragen

Neue Publikation eintragen

Neue Publikation holen aus...

...EVA

Fehlende Publikation melden

Highlights

Suche

Hilfe & Kontakt

Ansprechpartner

Hilfe

Datenschutz

Helmholtz Open Science

Bibliometrische Indikatoren

SHERPA/RoMEO

DOAJ

Export:

Text

Endnote (RIS) BIB

BibTeX

Trambauer, J.* ; Rodríguez Sarmiento, R.M.* ; Fukumori, A.* ; Feederle, R. ; Baumann, K.* ; Steiner, H.*

A beta 43-producing PS1 FAD mutants cause altered substrate interactions and respond to gamma-secretase modulation.

EMBO Rep. 21:e47996 (2020)

Verlagsversion

Forschungsdaten

DOI

PMC

	Open Access Hybrid

Abstract
Metriken
Zusatzinfos

Abnormal generation of neurotoxic amyloid-beta peptide (A beta) 42/43 species due to mutations in the catalytic presenilin 1 (PS1) subunit of gamma-secretase is the major cause of familial Alzheimer's disease (FAD). Deeper mechanistic insight on the generation of A beta 43 is still lacking, and it is unclear whether gamma-secretase modulators (GSMs) can reduce the levels of this A beta species. By comparing several types of A beta 43-generating FAD mutants, we observe that very high levels of A beta 43 are often produced when presenilin function is severely impaired. Altered interactions of C99, the precursor of A beta, are found for all mutants and are independent of their particular effect on A beta production. Furthermore, unlike previously described GSMs, the novel compound RO7019009 can effectively lower A beta 43 production of all mutants. Finally, substrate-binding competition experiments suggest that RO7019009 acts mechanistically after initial C99 binding. We conclude that altered C99 interactions are a common feature of diverse types of PS1 FAD mutants and that also patients with A beta 43-generating FAD mutations could in principle be treated by GSMs.

Impact Factor

Scopus SNIP

Web of Science
Times Cited

Scopus
Cited By

Altmetric

7.497

1.452